EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 135 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.57 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $7,889,000 | -80.0% | 100,000 | -79.9% | 0.40% | -85.9% |
| Q4 2016 | $39,527,000 | +1317466.7% | 498,198 | -8.5% | 2.81% | – |
| Q3 2016 | $3,000 | -100.0% | 544,770 | +81.6% | 0.00% | -100.0% |
| Q2 2016 | $11,637,000 | +53.5% | 300,000 | +60.2% | 0.81% | +21.4% |
| Q1 2016 | $7,582,000 | -35.8% | 187,215 | +40.6% | 0.66% | -23.8% |
| Q4 2015 | $11,806,000 | -35.2% | 133,145 | -45.9% | 0.87% | +19.9% |
| Q3 2015 | $18,218,000 | -3.3% | 246,088 | +5.6% | 0.73% | -35.9% |
| Q2 2015 | $18,844,000 | +3624.1% | 233,044 | +1827.9% | 1.14% | +2810.3% |
| Q1 2015 | $506,000 | – | 12,088 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |